首页> 外文OA文献 >KADAR PLASMINOGEN AKTIVATOR INHIBITOR-1 SEBAGAIudPREDIKTOR OUTCOME STATUS NEUROLOGIS PADA STROKEudISKEMIK AKUTud( Plasminogen activator inhibitor-1 level as predictor neurologic outcome in acuteudischemic stroke )

【2h】

KADAR PLASMINOGEN AKTIVATOR INHIBITOR-1 SEBAGAIudPREDIKTOR OUTCOME STATUS NEUROLOGIS PADA STROKEudISKEMIK AKUTud( Plasminogen activator inhibitor-1 level as predictor neurologic outcome in acuteudischemic stroke )

机译：抑制剂1的纤溶酶原水平脑卒中神经状态的预后指标急性缺血纤溶酶原激活物抑制剂-1水平作为急性神经系统预后的预测因子缺血性中风）

页面导航

著录项
相似文献
相关主题

著录项

作者
Patrisia Hygea Talita;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 {"code":"id","name":"Indonesian","id":20}
中图分类

相似文献

外文文献
中文文献
专利

1. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. [J] . Johansson L, Jansson JH, Boman K, Stroke: A Journal of Cerebral Circulation . 2000 ,第1期

机译：组织纤溶酶原激活物，纤溶酶原激活物抑制剂-1和组织纤溶酶原激活物/纤溶酶原激活物抑制剂-1复合物是发生中风的危险因素。
2. Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. [J] . Qin W, Zhu W, Wagner Mann C, Annals of surgical oncology . 2003 ,第8期

机译：尿激酶型纤溶酶原激活物，纤溶酶原激活物抑制剂-1和尿激酶型纤溶酶原激活物受体的乳头抽吸液表达可预测乳腺癌的诊断和晚期疾病。
3. Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome. [J] . Patrizia Ferroni, Mario Roselli, Ilaria Portarena, Anticancer Research: International Journal of Cancer Research and Treatment . 2014 ,第3期

机译：乳腺癌中的血浆纤溶酶原激活物抑制剂1（PAI-1）水平-与临床结果的关系。
4. Lack of association of 4G/5G polymorphism in plasminogen activator inhibitor-1 gene with stroke [C] . Masaru Shoji, Shoji Tsutaya, Chiyako Oshikata, Hirosaki International Forum of Medical Science . 2003

机译：血液原激活剂抑制剂-1基因中缺乏4g / 5g多态性的关联卒中
5. Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis [O] . L Lorente, M Martín, L Labarta, 2009

机译：4G / 5G纤溶酶原激活物抑制剂1（PAI-1）基因多态性和PAI-1血浆水平在严重脓毒症患者预后中的作用
6. Tissue Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex as Risk Factors for the Development of a First Stroke [O] . Lars Johansson, Jan-Håkan Jansson, Kurt Boman, 2000

机译：组织纤溶酶原激活剂，纤溶酶原激活剂抑制剂-1和组织纤溶酶原激活剂/纤溶酶原激活剂抑制剂-1复合物作为第一个中风发育的危险因素

KADAR PLASMINOGEN AKTIVATOR INHIBITOR-1 SEBAGAIudPREDIKTOR OUTCOME STATUS NEUROLOGIS PADA STROKEudISKEMIK AKUTud( Plasminogen activator inhibitor-1 level as predictor neurologic outcome in acuteudischemic stroke )

著录项

相似文献

相关主题

期刊订阅